CAMBRIDGE, England--(BUSINESS WIRE)--EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has been granted a European patent ...
A recent study investigated the effectiveness of the augmented binary method for investigating rare diseases in a small sample size. Composite endpoints consider a number of individual outcomes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results